VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q73917011  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000339.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q73917011‏
024 ‎‡a  0000-0002-9323-9437‏ ‎‡2  orcid‏
024 ‎‡a  7402412966‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q73917011‏
100 0 ‎‡a  নিকোলাস ইয়াং‏ ‎‡9  bn‏
400 0 ‎‡a  Nicholas Young‏ ‎‡c  researcher ORCID ID=0000-0002-9323-9437‏ ‎‡9  en‏
400 0 ‎‡a  Nicholas Young‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieu‏
670 ‎‡a  Author's Cy3-tilmanocept labeling of macrophages in joints of mice with antibody-induced arthritis and synovium of human patients with rheumatoid arthritis‏
670 ‎‡a  Author's Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis‏
670 ‎‡a  Author's Physical activity prevents acute inflammation in a gout model by downregulation of TLR2 on circulating neutrophils as well as inhibition of serum CXCL1 and is associated with decreased pain and inflammation in gout patients‏
670 ‎‡a  Author's Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness.‏
670 ‎‡a  Author's Signal transduction of sphingosine-1-phosphate G protein-coupled receptors.‏
670 ‎‡a  Author's Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61‏
670 ‎‡a  Author's Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells.‏
909 ‎‡a  (orcid) 0000000293239437‏ ‎‡9  1‏
909 ‎‡a  (scopus) 7402412966‏ ‎‡9  1‏
919 ‎‡a  aberrantmuscleantigenexposureinmiceissufficienttocausemyositisinatregcelldeficientmilieu‏ ‎‡A  Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieu‏ ‎‡9  1‏
919 ‎‡a  cy3tilmanoceptlabelingofmacrophagesinjointsofmicewithantibodyinducedarthritisandsynoviumofhumanpatientswithrheumatoidarthritis‏ ‎‡A  Cy3-tilmanocept labeling of macrophages in joints of mice with antibody-induced arthritis and synovium of human patients with rheumatoid arthritis‏ ‎‡9  1‏
919 ‎‡a  pathologicalmanifestationofautoimmunemyocarditisisdetectedpriortoglomerulonephritisinamurinemodeloflupusnephritis‏ ‎‡A  Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis‏ ‎‡9  1‏
919 ‎‡a  physicalactivitypreventsacuteinflammationinagoutmodelbydownregulationoftlr2oncirculatingneutrophilsaswellasinhibitionofserumcxcl1andisassociatedwithdecreasedpainandinflammationingoutpatients‏ ‎‡A  Physical activity prevents acute inflammation in a gout model by downregulation of TLR2 on circulating neutrophils as well as inhibition of serum CXCL1 and is associated with decreased pain and inflammation in gout patients‏ ‎‡9  1‏
919 ‎‡a  rolesofsphingosine1phosphates1preceptorsinmalignantbehaviorofgliomacellsdifferentialeffectsofs1p2oncellmigrationandinvasiveness‏ ‎‡A  Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness.‏ ‎‡9  1‏
919 ‎‡a  signaltransductionofsphingosine1phosphategproteincoupledreceptors‏ ‎‡A  Signal transduction of sphingosine-1-phosphate G protein-coupled receptors.‏ ‎‡9  1‏
919 ‎‡a  sphingosine1phosphateregulatesglioblastomacellinvasivenessthroughtheurokinaseplasminogenactivatorsystemandccn1cyr61‏ ‎‡A  Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61‏ ‎‡9  1‏
919 ‎‡a  sphingosine1phosphatestimulatesmotilityandinvasivenessofhumanglioblastomamultiformecells‏ ‎‡A  Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells.‏ ‎‡9  1‏
996 ‎‡2  LC|n 2009000538
996 ‎‡2  LC|n 2009037377
996 ‎‡2  LC|no2017036394
996 ‎‡2  NTA|073833614
996 ‎‡2  ISNI|0000000002600908
996 ‎‡2  NUKAT|n 2007148237
996 ‎‡2  NUKAT|n 2014191393
996 ‎‡2  SUDOC|028754565
996 ‎‡2  ISNI|0000000026397588
996 ‎‡2  SUDOC|138961980
996 ‎‡2  CAOONL|ncf11331850
996 ‎‡2  NUKAT|n 2010152590
996 ‎‡2  LC|nb2005008993
996 ‎‡2  DNB|1092199721
996 ‎‡2  ISNI|000000038499434X
996 ‎‡2  LC|no2020014613
996 ‎‡2  NII|DA02464716
996 ‎‡2  LC|no2010035857
996 ‎‡2  NTA|067934110
996 ‎‡2  RERO|A024835692
996 ‎‡2  CAOONL|ncf12140878
996 ‎‡2  LC|no2011067135
996 ‎‡2  PTBNP|1580737
996 ‎‡2  ISNI|0000000044547690
996 ‎‡2  ISNI|0000000501160142
996 ‎‡2  SUDOC|137924895
996 ‎‡2  W2Z|1707990460869
996 ‎‡2  CAOONL|ncf11562971
996 ‎‡2  BIBSYS|12025340
996 ‎‡2  LC|no 00000581
996 ‎‡2  LC|n 93082135
996 ‎‡2  BNC|981058518575106706
996 ‎‡2  DNB|1221689541
996 ‎‡2  J9U|987007446540305171
996 ‎‡2  J9U|987007337037705171
996 ‎‡2  J9U|987007425004105171
996 ‎‡2  NII|DA02587603
996 ‎‡2  BNF|12052545
996 ‎‡2  J9U|987007332580805171
996 ‎‡2  DNB|1147320144
996 ‎‡2  DNB|1158571976
996 ‎‡2  LC|no2006013745
996 ‎‡2  LC|no2003108985
996 ‎‡2  LC|no2024042859
996 ‎‡2  CAOONL|ncf10414099
996 ‎‡2  CAOONL|ncf10030069
996 ‎‡2  DNB|141848073
996 ‎‡2  LC|n 88618803
996 ‎‡2  BIBSYS|10037679
996 ‎‡2  LC|n 90620840
996 ‎‡2  LC|n 83319234
996 ‎‡2  LC|nb2007026356
996 ‎‡2  BIBSYS|90754269
996 ‎‡2  LC|no2010135435
996 ‎‡2  LC|n 2024050089
996 ‎‡2  ISNI|0000000051886236
996 ‎‡2  NII|DA0561745X
996 ‎‡2  LC|nb2014012253
996 ‎‡2  ISNI|0000000074216526
996 ‎‡2  LC|n 2014049115
996 ‎‡2  ISNI|0000000050230331
996 ‎‡2  NUKAT|n 2010140128
996 ‎‡2  ISNI|0000000062524011
996 ‎‡2  ISNI|0000000031997190
996 ‎‡2  J9U|987007288534905171
996 ‎‡2  ISNI|000000007826826X
996 ‎‡2  BIBSYS|90244101
996 ‎‡2  ISNI|000000037777199X
996 ‎‡2  ISNI|000000038440598X
996 ‎‡2  LC|n 2012048012
996 ‎‡2  DNB|1079632743
996 ‎‡2  BNF|16758326
996 ‎‡2  SUDOC|147165024
996 ‎‡2  B2Q|0000759681
996 ‎‡2  RERO|A003992646
996 ‎‡2  BIBSYS|90540565
996 ‎‡2  DNB|1282578065
996 ‎‡2  PLWABN|9810553820105606
996 ‎‡2  CAOONL|ncf10639672
996 ‎‡2  ISNI|0000000103170345
996 ‎‡2  J9U|987007270152805171
996 ‎‡2  SUDOC|179006061
996 ‎‡2  CAOONL|ncf10524533
996 ‎‡2  LC|no2024101170
996 ‎‡2  NII|DA13288987
996 ‎‡2  DNB|1220728594
996 ‎‡2  ISNI|0000000385957364
996 ‎‡2  SUDOC|192296507
996 ‎‡2  ISNI|000000007737823X
996 ‎‡2  LC|nb2018016543
996 ‎‡2  ISNI|0000000053174005
996 ‎‡2  NII|DA09004259
996 ‎‡2  NDL|001124981
996 ‎‡2  LC|nb2011023795
996 ‎‡2  ISNI|0000000066342602
996 ‎‡2  LC|nr 93019326
996 ‎‡2  RERO|A018043632
996 ‎‡2  ISNI|0000000139072050
996 ‎‡2  NYNYRILM|18315
996 ‎‡2  BAV|495_266839
996 ‎‡2  LC|n 2023012070
996 ‎‡2  ISNI|0000000041007912
996 ‎‡2  PLWABN|9810568026405606
996 ‎‡2  LC|n 89650664
996 ‎‡2  DNB|1022111760
996 ‎‡2  LC|no2020014419
996 ‎‡2  J9U|987007335459005171
996 ‎‡2  LC|n 88638462
996 ‎‡2  BIBSYS|1707990460869
996 ‎‡2  LC|nr2004034901
996 ‎‡2  N6I|vtls000022849
996 ‎‡2  LC|nr 96023404
996 ‎‡2  DBC|87097969759971
996 ‎‡2  DNB|1048416712
996 ‎‡2  RERO|A003992619
996 ‎‡2  RERO|A003992618
996 ‎‡2  SUDOC|081513690
996 ‎‡2  LC|n 2006086646
996 ‎‡2  DNB|139267492
996 ‎‡2  LC|n 80145489
996 ‎‡2  CAOONL|ncf11554431
996 ‎‡2  DE633|pe30031017
996 ‎‡2  BNE|XX1785649
996 ‎‡2  PLWABN|9810617597005606
996 ‎‡2  NTA|07435910X
996 ‎‡2  DNB|1185709320
996 ‎‡2  LC|n 88601888
996 ‎‡2  LC|n 87865484
996 ‎‡2  ISNI|0000000115782939
996 ‎‡2  LC|n 84002842
996 ‎‡2  BAV|495_263048
996 ‎‡2  BNF|15618287
996 ‎‡2  SUDOC|238386384
996 ‎‡2  NKC|xx0230332
996 ‎‡2  BNF|15105944
996 ‎‡2  ISNI|0000000501152177
996 ‎‡2  BNC|981058511509806706
996 ‎‡2  SUDOC|248245821
996 ‎‡2  PLWABN|9810543322905606
996 ‎‡2  NTA|342147730
996 ‎‡2  DBC|87097992546098
996 ‎‡2  DNB|1194347371
996 ‎‡2  BIBSYS|46695
996 ‎‡2  ISNI|0000000036253748
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏